The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus

被引:98
作者
Sáiz, JC [1 ]
López-Labrador, FX
Ampurdanés, S
Dopazo, J
Forns, X
Sánchez-Tapias, JM
Rodés, J
机构
[1] Univ Barcelona, Fac Med, Liver Unit, Hosp Clin,Dept Med, Barcelona 7, Spain
[2] Poligono Ind Alcobendas, Soc Anon, Madrid, Spain
关键词
D O I
10.1086/515243
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis C virus (HCV) RNA serum concentration, quasispecies complexity, and sequence and phylogenetic analysis of the nonstructural 5A gene (NS5A) interferon sensitivity determining region (ISDR) were determined in pretreatment serum samples from 47 patients with chronic hepatitis C (36 infected by HCV genotype 1b and 11 by 3a). Among HCV genotype 1b-infected patients, virus load was lower (P =.003) and the number of NS5A-ISDR amino acid changes was higher (P = .001) in long-term responders than in non-long-term responders, but there were no differences in quasispecies complexity. Multivariate analysis showed a close association between response to interferon and NS5A-ISDR phenotype, Phylogenetic analysis showed that isolates from non-long-term responders clustered apart from the majority of isolates from long-term responders. There was no association between virologic features and therapeutic response in HCV genotype 3a-infected patients, In conclusion, low virus load and mutant NS5A-ISDR phenotype are closely associated with long-term response to interferon in HCV genotype 1b- but probably not in 3a-infected patients.
引用
收藏
页码:839 / 847
页数:9
相关论文
共 60 条
[11]   Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein [J].
Gale, MJ ;
Korth, MJ ;
Tang, NM ;
Tan, SL ;
Hopkins, DA ;
Dever, TE ;
Polyak, SJ ;
Gretch, DR ;
Katze, MG .
VIROLOGY, 1997, 230 (02) :217-227
[12]  
GonzalezPeralta RP, 1996, J MED VIROL, V49, P242, DOI 10.1002/(SICI)1096-9071(199607)49:3<242::AID-JMV14>3.0.CO
[13]  
2-E
[14]   QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
GASTROENTEROLOGY, 1993, 104 (03) :877-883
[15]  
Hayashi S., 1996, Hepatology, V24, p158A
[16]  
Hige S., 1996, Hepatology, V24, p164A
[17]   NON-A, NON-B CHRONIC HEPATITIS IS CHRONIC HEPATITIS-C - A SENSITIVE ASSAY FOR DETECTION OF HEPATITIS-C VIRUS-RNA IN THE LIVER [J].
HOSODA, K ;
OMATA, M ;
YOKOSUKA, O ;
KATO, N ;
OHTO, M .
HEPATOLOGY, 1992, 15 (05) :777-781
[18]   PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS AMONG PATIENTS WITH CRYPTOGENIC CHRONIC HEPATITIS AND CIRRHOSIS [J].
JEFFERS, LJ ;
HASAN, F ;
DEMEDINA, M ;
REDDY, R ;
PARKER, T ;
SILVA, M ;
MENDEZ, L ;
SCHIFF, ER ;
MANNS, M ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
HEPATOLOGY, 1992, 15 (02) :187-190
[19]  
Jukes T. H., 1969, MAMMALIAN PROTEIN ME, P121, DOI DOI 10.1016/B978-1-4832-3211-9.50009-7
[20]   INFLUENCE OF VIRAL QUASI-SPECIES ON EFFECTIVENESS OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C PATIENTS [J].
KANAZAWA, Y ;
HAYASHI, N ;
MITA, E ;
LI, TC ;
HAGIWARA, H ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1994, 20 (05) :1121-1130